Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 609
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05524935 | Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma | ||
| NCT00216008 | Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation. | ||
| NCT00005613 | Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | ||
| NCT06219174 | Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO) | ||
| NCT03177291 | Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC | ||
| NCT01534078 | Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma | ||
| NCT00005615 | Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa | ||
| NCT02745756 | A Combined Cell Therapy Approach to the Treatment of Neuroblastoma | ||
| NCT02634645 | TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) | ||
| NCT02187822 | Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases | ||
| NCT00720629 | Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation | ||
| NCT00606008 | A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma | ||
| NCT05024552 | Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML | ||
| NCT03077126 | Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer | ||
| NCT07447635 | Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors | ||
| NCT05341882 | Adaptation of Mindfulness Training to Treat Moral Injury in Veterans | ||
| NCT01176474 | Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma | ||
| NCT02721459 | XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma | ||
| NCT00082641 | Neoadjuvant/Adjuvant Chemotherapy, Vaccine & Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast Cancer | ||
| NCT00840931 | Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS) | ||
| NCT01659151 | Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma | ||
| NCT05775068 | ARtificial Intelligence for Gross Tumour vOlume Segmentation | ||
| NCT01133275 | Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS | ||
| NCT07476001 | Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC | ||
| NCT04562129 | IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients | ||
| NCT04869137 | Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma | ||
| NCT05064085 | Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer | ||
| NCT05083416 | Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome | ||
| NCT03924778 | Modifying Diet to Improve Gut Microbiome | ||
| NCT00815685 | A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia | ||
| NCT00948922 | Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma | ||
| NCT00299481 | Tissue Bank of Biological Specimens From Patients With Gynecologic Disease | ||
| NCT00365872 | External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma | ||
| NCT03290079 | Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors | ||
| NCT06121180 | Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma | ||
| NCT03834623 | Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma | ||
| NCT02652455 | Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma | ||
| NCT05763563 | Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy | ||
| NCT05267587 | Preop fSRS for Resectable Brain Metastases | ||
| NCT06236425 | TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC | ||
| NCT00226590 | Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC | ||
| NCT04741997 | Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma | ||
| NCT02796391 | Facilitating Smoking Cessation With Reduced Nicotine Cigarettes | ||
| NCT05189457 | First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer | ||
| NCT06745882 | Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC | ||
| NCT06328127 | Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors | ||
| NCT01010854 | Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer | ||
| NCT06660368 | BCL2i CLAG-M in R/R Acute Myeloid Leukemia | ||
| NCT00005626 | Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11) | ||
| NCT01496976 | Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL |
